Azenta, Inc. (AZTA)
USD 49.65
(7.21%)
USD 49.65
(7.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 665.07 Million USD | 19.73% |
| 2022 | 555.49 Million USD | 8.14% |
| 2021 | 513.7 Million USD | -42.75% |
| 2020 | 897.27 Million USD | 14.76% |
| 2019 | 781.86 Million USD | 23.8% |
| 2018 | 631.56 Million USD | -8.85% |
| 2017 | 692.88 Million USD | 23.66% |
| 2016 | 560.32 Million USD | 1.38% |
| 2015 | 552.7 Million USD | 14.47% |
| 2014 | 482.84 Million USD | 7.07% |
| 2013 | 450.95 Million USD | -13.19% |
| 2012 | 519.45 Million USD | -24.51% |
| 2011 | 688.1 Million USD | 16.04% |
| 2010 | 592.97 Million USD | 171.13% |
| 2009 | 218.7 Million USD | -58.45% |
| 2008 | 526.36 Million USD | -29.18% |
| 2007 | 743.25 Million USD | 7.27% |
| 2006 | 692.87 Million USD | 49.41% |
| 2005 | 463.74 Million USD | -14.08% |
| 2004 | 539.76 Million USD | 57.09% |
| 2003 | 343.61 Million USD | 12.94% |
| 2002 | 304.25 Million USD | -20.29% |
| 2001 | 381.71 Million USD | 18.88% |
| 2000 | 321.09 Million USD | 209.05% |
| 1999 | 103.9 Million USD | 4.0% |
| 1998 | 99.9 Million USD | 15.63% |
| 1997 | 86.4 Million USD | -4.42% |
| 1996 | 90.4 Million USD | 97.81% |
| 1995 | 45.7 Million USD | 90.42% |
| 1994 | 24 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q1 | 154.31 Million USD | -10.47% |
| 2024 Q3 | 172.8 Million USD | 8.59% |
| 2024 Q2 | 159.13 Million USD | 3.12% |
| 2023 Q3 | 165.94 Million USD | 11.82% |
| 2023 FY | 665.07 Million USD | 19.73% |
| 2023 Q1 | 178.36 Million USD | 29.66% |
| 2023 Q4 | 172.35 Million USD | 3.86% |
| 2023 Q2 | 148.4 Million USD | -16.8% |
| 2022 Q2 | 145.54 Million USD | 4.22% |
| 2022 FY | 555.49 Million USD | 8.14% |
| 2022 Q1 | 139.65 Million USD | 1.98% |
| 2022 Q4 | 137.56 Million USD | 3.64% |
| 2022 Q3 | 132.73 Million USD | -8.8% |
| 2021 Q2 | 286.58 Million USD | 14.86% |
| 2021 FY | 513.7 Million USD | -42.75% |
| 2021 Q4 | 136.93 Million USD | -56.58% |
| 2021 Q3 | 315.34 Million USD | 10.04% |
| 2021 Q1 | 249.5 Million USD | 1.34% |
| 2020 Q4 | 246.19 Million USD | 11.73% |
| 2020 Q1 | 210.5 Million USD | 5.13% |
| 2020 Q3 | 220.35 Million USD | 0.06% |
| 2020 FY | 897.27 Million USD | 14.76% |
| 2020 Q2 | 220.22 Million USD | 4.62% |
| 2019 Q4 | 200.22 Million USD | -1.79% |
| 2019 Q1 | 179.36 Million USD | 12.35% |
| 2019 Q3 | 203.88 Million USD | 2.77% |
| 2019 Q2 | 198.39 Million USD | 10.61% |
| 2019 FY | 781.86 Million USD | 23.8% |
| 2018 Q2 | 207.26 Million USD | 9.47% |
| 2018 FY | 631.56 Million USD | -8.85% |
| 2018 Q1 | 189.32 Million USD | 4.1% |
| 2018 Q3 | 223.48 Million USD | 7.83% |
| 2018 Q4 | 159.64 Million USD | -28.56% |
| 2017 FY | 692.88 Million USD | 23.66% |
| 2017 Q3 | 181.71 Million USD | 7.31% |
| 2017 Q4 | 181.88 Million USD | 0.09% |
| 2017 Q2 | 169.33 Million USD | 5.86% |
| 2017 Q1 | 159.95 Million USD | 1.52% |
| 2016 FY | 560.32 Million USD | 1.38% |
| 2016 Q3 | 147.53 Million USD | 9.06% |
| 2016 Q2 | 135.28 Million USD | 12.78% |
| 2016 Q1 | 119.95 Million USD | -17.71% |
| 2016 Q4 | 157.55 Million USD | 6.79% |
| 2015 FY | 552.7 Million USD | 14.47% |
| 2015 Q3 | 144.89 Million USD | 4.01% |
| 2015 Q2 | 139.31 Million USD | 13.51% |
| 2015 Q4 | 145.76 Million USD | 0.6% |
| 2015 Q1 | 122.73 Million USD | 0.18% |
| 2014 Q1 | 124.58 Million USD | 5.37% |
| 2014 Q2 | 125.9 Million USD | 1.05% |
| 2014 Q4 | 122.51 Million USD | 4.4% |
| 2014 Q3 | 117.35 Million USD | -6.78% |
| 2014 FY | 482.84 Million USD | 7.07% |
| 2013 Q2 | 116.61 Million USD | 18.97% |
| 2013 FY | 450.95 Million USD | -13.19% |
| 2013 Q4 | 118.23 Million USD | 0.14% |
| 2013 Q3 | 118.07 Million USD | 1.25% |
| 2013 Q1 | 98.02 Million USD | -17.94% |
| 2012 Q2 | 139.33 Million USD | 15.89% |
| 2012 Q3 | 140.43 Million USD | 0.79% |
| 2012 Q4 | 119.44 Million USD | -14.94% |
| 2012 FY | 519.45 Million USD | -24.51% |
| 2012 Q1 | 120.22 Million USD | -8.19% |
| 2011 Q2 | 192.65 Million USD | 8.01% |
| 2011 FY | 688.1 Million USD | 16.04% |
| 2011 Q4 | 130.95 Million USD | -29.65% |
| 2011 Q1 | 178.36 Million USD | -1.8% |
| 2011 Q3 | 186.13 Million USD | -3.38% |
| 2010 Q1 | 106.19 Million USD | 65.71% |
| 2010 FY | 592.97 Million USD | 171.13% |
| 2010 Q2 | 148.35 Million USD | 39.7% |
| 2010 Q3 | 156.79 Million USD | 5.69% |
| 2010 Q4 | 181.63 Million USD | 15.84% |
| 2009 FY | 218.7 Million USD | -58.45% |
| 2009 Q4 | 64.08 Million USD | 46.06% |
| 2009 Q3 | 43.87 Million USD | 17.63% |
| 2009 Q1 | 73.44 Million USD | -31.28% |
| 2009 Q2 | 37.29 Million USD | -49.21% |
| 2008 FY | 526.36 Million USD | -29.18% |
| 2008 Q4 | 106.87 Million USD | -13.83% |
| 2008 Q3 | 124.01 Million USD | -16.01% |
| 2008 Q2 | 147.64 Million USD | -0.13% |
| 2008 Q1 | 147.83 Million USD | -11.21% |
| 2007 FY | 743.25 Million USD | 7.27% |
| 2007 Q4 | 166.5 Million USD | -12.58% |
| 2007 Q3 | 190.46 Million USD | -2.29% |
| 2007 Q2 | 194.92 Million USD | 1.86% |
| 2007 Q1 | 191.36 Million USD | -9.01% |
| 2006 Q1 | 127.17 Million USD | 23.11% |
| 2006 FY | 692.87 Million USD | 49.41% |
| 2006 Q3 | 186.19 Million USD | 10.06% |
| 2006 Q2 | 169.17 Million USD | 33.03% |
| 2006 Q4 | 210.32 Million USD | 12.96% |
| 2005 Q3 | 113.76 Million USD | -12.14% |
| 2005 Q1 | 117.81 Million USD | -28.16% |
| 2005 FY | 463.74 Million USD | -14.08% |
| 2005 Q4 | 103.29 Million USD | -9.2% |
| 2005 Q2 | 129.47 Million USD | 9.89% |
| 2004 Q2 | 137.98 Million USD | 67.16% |
| 2004 Q4 | 164 Million USD | 5.65% |
| 2004 Q1 | 82.54 Million USD | 0.98% |
| 2004 Q3 | 155.23 Million USD | 12.5% |
| 2004 FY | 539.76 Million USD | 57.09% |
| 2003 Q1 | 84.85 Million USD | -17.77% |
| 2003 FY | 343.61 Million USD | 12.94% |
| 2003 Q4 | 81.74 Million USD | -2.74% |
| 2003 Q3 | 84.04 Million USD | -9.59% |
| 2003 Q2 | 92.96 Million USD | 9.56% |
| 2002 FY | 304.25 Million USD | -20.29% |
| 2002 Q1 | 61.45 Million USD | -14.21% |
| 2002 Q2 | 58.31 Million USD | -5.11% |
| 2002 Q3 | 85.76 Million USD | 47.06% |
| 2002 Q4 | 103.18 Million USD | 20.32% |
| 2001 Q2 | 111.16 Million USD | 3.33% |
| 2001 Q4 | 71.63 Million USD | -23.61% |
| 2001 Q3 | 93.76 Million USD | -15.65% |
| 2001 FY | 381.71 Million USD | 18.88% |
| 2001 Q1 | 107.57 Million USD | 8.32% |
| 2000 Q4 | 99.31 Million USD | 13.08% |
| 2000 Q1 | 50.3 Million USD | 45.8% |
| 2000 Q3 | 87.82 Million USD | 20.29% |
| 2000 Q2 | 73.01 Million USD | 45.15% |
| 2000 FY | 321.09 Million USD | 209.05% |
| 1999 FY | 103.9 Million USD | 4.0% |
| 1999 Q4 | 34.5 Million USD | 30.68% |
| 1999 Q3 | 26.4 Million USD | 13.3% |
| 1999 Q2 | 23.3 Million USD | 17.68% |
| 1999 Q1 | 19.8 Million USD | -39.45% |
| 1998 Q2 | 20.2 Million USD | -17.89% |
| 1998 Q1 | 24.6 Million USD | -20.13% |
| 1998 FY | 99.9 Million USD | 15.63% |
| 1998 Q4 | 32.7 Million USD | 46.64% |
| 1998 Q3 | 22.3 Million USD | 10.4% |
| 1997 Q3 | 23.1 Million USD | 40.85% |
| 1997 Q2 | 16.4 Million USD | 1.86% |
| 1997 Q4 | 30.8 Million USD | 33.33% |
| 1997 FY | 86.4 Million USD | -4.42% |
| 1997 Q1 | 16.1 Million USD | -32.92% |
| 1996 Q4 | 24 Million USD | -5.14% |
| 1996 FY | 90.4 Million USD | 97.81% |
| 1996 Q3 | 25.3 Million USD | 11.95% |
| 1996 Q2 | 22.6 Million USD | 34.52% |
| 1996 Q1 | 16.8 Million USD | 15.86% |
| 1995 FY | 45.7 Million USD | 90.42% |
| 1995 Q4 | 14.5 Million USD | 14.17% |
| 1995 Q2 | 10 Million USD | 19.05% |
| 1995 Q3 | 12.7 Million USD | 27.0% |
| 1995 Q1 | 8.4 Million USD | 0.0% |
| 1994 FY | 24 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | -588.245% |
| AngioDynamics, Inc. | 303.91 Million USD | -118.836% |
| AtriCure, Inc. | 399.24 Million USD | -66.582% |
| Avinger, Inc. | 7.65 Million USD | -8591.479% |
| BioLife Solutions, Inc. | 143.27 Million USD | -364.206% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 81.491% |
| Daxor Corporation | 1.28 Million USD | -51837.853% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -3538.448% |
| Femasys Inc. | 1.07 Million USD | -61942.035% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | -492.492% |
| Hologic, Inc. | 4.03 Billion USD | 83.498% |
| ICU Medical, Inc. | 2.25 Billion USD | 70.561% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 90.664% |
| KORU Medical Systems, Inc. | 28.51 Million USD | -2232.14% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | -243.735% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -57607.95% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -57607.95% |
| Masimo Corporation | 2.04 Billion USD | 67.527% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | -584.943% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 47.106% |
| Nephros, Inc. | 14.23 Million USD | -4571.105% |
| NovoCure Limited | 509.33 Million USD | -30.576% |
| NEXGEL, Inc. | 4.08 Million USD | -16164.906% |
| NEXGEL, Inc. | 4.08 Million USD | -16164.906% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -22746.857% |
| OraSure Technologies, Inc. | 405.47 Million USD | -64.024% |
| Pro-Dex, Inc. | 53.84 Million USD | -1135.183% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -37261.643% |
| Precision Optics Corporation, Inc. | 19.1 Million USD | -3381.26% |
| QuidelOrtho Corporation | 2.99 Billion USD | 77.815% |
| Repligen Corporation | 638.76 Million USD | -4.119% |
| Sanara MedTech Inc. | 64.98 Million USD | -923.348% |
| STAAR Surgical Company | 322.41 Million USD | -106.278% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | -1224.212% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 83.226% |
| Jin Medical International Ltd. | 19.82 Million USD | -3255.313% |